NCT05654311 is a clinical trial of Nasal surgery in Nasal Surgery, sponsored by Gangnam Severance Hospital.

Who is sponsoring NCT05654311?

NCT05654311 is sponsored by Gangnam Severance Hospital.

What drugs are being tested in NCT05654311?

Interventions in NCT05654311: Nasal surgery.

What condition does NCT05654311 study?

NCT05654311 studies Nasal Surgery.

Is NCT05654311 still recruiting?

NCT05654311 is currently recruiting now. Last updated 8 April 2024.

Last reviewed 2024-04-08 · How we verify

NCT05654311

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Performance of EEG During Emergence Agitation in Nasal Surgery.

Recruiting now Last updated 8 April 2024

What this trial tests

trial testing Nasal surgery in Nasal Surgery in 55 participants. Currently enrolling.

Timeline

2 January 2023

Primary endpoint
26 October 2024

26 October 2024

Quick facts

Lead sponsor	Gangnam Severance Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	55
Start date	2 January 2023
Primary completion	26 October 2024
Estimated completion	26 October 2024
Sites	1 location across South Korea

Drugs / interventions tested

Nasal surgery

Conditions studied

Nasal Surgery — all drugs for Nasal Surgery →

Sponsor

Gangnam Severance Hospital

Who can join

Adults 19 to 55, any sex, with Nasal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the relationship between perioperative electroencephalogram and emergence agitation in the nasal surgery. Previous studies showed that low frequency band wave activity increased during emergence delirium in pediatric patients. It is still not enough to explain the relationship between emergence agitation and electroencephalogram in adults. Researchers will demonstrate the relationship between parameters related electroencephalogram and emergence agitation in adults undergoing nasal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nasal Surgery

Currently open trials in the same condition.

NCT07253428 — Emergence Agitation · NA · active not recruiting

Other Gangnam Severance Hospital trials

Trials by the same sponsor.

NCT07505628 — AI-based Rehabilitation for Hip and Knee Surgery Patients · NA · not yet recruiting
NCT07311122 — Endocrine Therapy Base on 21-gene RS · not yet recruiting
NCT07011823 — Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC · Phase 2 · not yet recruiting
NCT07211451 — Axillary Nodal Burden in HER2+ and TNBC · completed
NCT06839716 — Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05654311 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gangnam Severance Hospital
Last refreshed: 8 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05654311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing